Healthcare provider profile · identity verified

Amy L Moser, CNP

Nurse Practitioner · EAST PALESTINE, OH · NPI 1669706255

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	398	87
Atorvastatin Calcium	Atorvastatin Calcium	326	97
Metoprolol Succinate	Metoprolol Succinate	246	60
Gabapentin	Gabapentin	244	48
Omeprazole	Omeprazole	224	51
Lisinopril	Lisinopril	210	57
Metformin Hcl	Metformin Hcl	139	39
Albuterol Sulfate Hfa	Albuterol Sulfate	136	50
Amlodipine Besylate	Amlodipine Besylate	136	45
Pantoprazole Sodium	Pantoprazole Sodium	134	32
Meloxicam	Meloxicam	130	33
Losartan Potassium	Losartan Potassium	129	34
Jardiance	Empagliflozin	119	23
Sertraline Hcl	Sertraline Hcl	119	31
Tramadol Hcl	Tramadol Hcl	115	24
Rosuvastatin Calcium	Rosuvastatin Calcium	114	33
Lorazepam	Lorazepam	112	25
Prednisone	Prednisone	112	79
Hydrochlorothiazide	Hydrochlorothiazide	110	26
Eliquis	Apixaban	104	26
Nystatin	Nystatin	101	32
Furosemide	Furosemide	100	35
Alendronate Sodium	Alendronate Sodium	98	22
Simvastatin	Simvastatin	96	30
Montelukast Sodium	Montelukast Sodium	94	21
Alprazolam	Alprazolam	93	19
Doxycycline Hyclate	Doxycycline Hyclate	89	74
Fluticasone Propionate	Fluticasone Propionate	88	23
Allopurinol	Allopurinol	80	20
Potassium Chloride	Potassium Chloride	75	23
Celecoxib	Celecoxib	74	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	74	21
Clonazepam	Clonazepam	73	11
Metoprolol Tartrate	Metoprolol Tartrate	69	23
Escitalopram Oxalate	Escitalopram Oxalate	68	17
Glipizide	Glipizide	66	17
Ropinirole Hcl	Ropinirole Hcl	62	12
Trazodone Hcl	Trazodone Hcl	62	19
Donepezil Hcl	Donepezil Hcl	60	suppressed
Warfarin Sodium	Warfarin Sodium	59	12
Oxybutynin Chloride Er	Oxybutynin Chloride	58	11
Venlafaxine Hcl Er	Venlafaxine Hcl	58	15
Famotidine	Famotidine	57	12
Methylprednisolone	Methylprednisolone	57	49
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	56	50
Triamcinolone Acetonide	Triamcinolone Acetonide	56	23
Citalopram Hbr	Citalopram Hydrobromide	54	17
Mirtazapine	Mirtazapine	54	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	53	14
Ozempic	Semaglutide	52	12
Fenofibrate	Fenofibrate	51	12
Myrbetriq	Mirabegron	51	suppressed
Linzess	Linaclotide	50	suppressed
Pregabalin	Pregabalin	48	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	48	11
Naproxen	Naproxen	47	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	14
Azithromycin	Azithromycin	45	38
Meclizine Hcl	Meclizine Hcl	45	14
Vascepa	Icosapent Ethyl	45	suppressed
Baclofen	Baclofen	41	suppressed
Divalproex Sodium	Divalproex Sodium	40	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	40	suppressed
Rybelsus	Semaglutide	38	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	38	30
Synthroid	Levothyroxine Sodium	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Metformin Hcl Er	Metformin Hcl	36	suppressed
Ondansetron Odt	Ondansetron	35	26
Bumetanide	Bumetanide	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Bupropion Xl	Bupropion Hcl	32	suppressed
Mupirocin	Mupirocin	31	27
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	31	11
Topiramate	Topiramate	30	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	11
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	20
Tizanidine Hcl	Tizanidine Hcl	26	suppressed
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Tradjenta	Linagliptin	24	suppressed
Fluconazole	Fluconazole	23	20
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Memantine Hcl	Memantine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Levofloxacin	Levofloxacin	22	22
Amoxicillin	Amoxicillin	21	15
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fentanyl	Fentanyl	21	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Carvedilol	Carvedilol	20	suppressed
Clotrimazole	Clotrimazole	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Sucralfate	Sucralfate	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Cephalexin	Cephalexin	16	15
Januvia	Sitagliptin Phosphate	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Phenobarbital	Phenobarbital	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Misoprostol	Misoprostol	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Cefdinir	Cefdinir	14	11
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Prempro	Estrogen,con/M-Progest Acet	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Atenolol	Atenolol	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Exelon	Rivastigmine	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error